We are live on !
Find out more
Axa Portfolio holdings
AUM
$91.9M
Turnover
57.14%
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter Est. Return
+3.61%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.62%
5 Year Est. Return
+129.91%
10 Year Est. Return
+554.84%
AUM
$22B
AUM Growth
-$123M
(-0.55%)
Cap. Flow
-$1.19B
Cap. Flow % of AUM
Cap. Flow %
-5.42%
Top 10 Holdings %
Top 10 Hldgs %
11.79%
Holding
1,359
New
101
Increased
421
Reduced
517
Closed
125
Avg Time Held
2.4
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$62M |
| 2 |
UBS Group
UBS
|
+$49.7M |
| 3 |
Air Products & Chemicals
APD
|
+$47.3M |
| 4 |
AT&T
T
|
+$44.6M |
| 5 |
Lam Research
LRCX
|
+$39.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hewlett Packard
HPE
|
+$61.6M |
| 2 |
HCA Healthcare
HCA
|
+$50.8M |
| 3 |
Gen Digital
GEN
|
+$50.7M |
| 4 |
Baxter International
BAX
|
+$50.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$49.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 16.86% |
| 3 | Financials | 11.57% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.06T
| $540M | 2.45% |
15,010,828
+128,904
| +0.9% | +$4.77M |
2013 Q2
16 quarters
|
|
|
2
Johnson & Johnson
JNJ
$666B
| $260M | 1.18% |
1,963,317
-385,039
| -16% | -$49.1M |
2013 Q2
16 quarters
|
|
3
Microsoft
MSFT
$3.86T
| $238M | 1.08% |
3,445,707
-276,225
| -7% | -$19M |
2013 Q2
16 quarters
|
|
4
TechnipFMC
FTI
$26.6B
| $237M | 1.07% |
11,689,186
+1,642,469
| +16% | +$37M |
2013 Q2
16 quarters
|
|
5
Alphabet (Google) Class A
GOOGL
$3.43T
| $233M | 1.06% |
5,019,220
-422,200
| -8% | -$19.7M |
2015 Q4
6 quarters
|
|
6
Amazon
AMZN
$2.57T
| $229M | 1.04% |
4,741,460
+137,580
| +3% | +$6.56M |
2013 Q2
16 quarters
|
|
7
Alphabet (Google) Class C
GOOG
$3.4T
| $228M | 1.04% |
5,019,440
+41,800
| +0.8% | +$1.91M |
2015 Q4
6 quarters
|
|
8
Gilead Sciences
GILD
$214B
| $219M | 0.99% |
3,087,805
-564,456
| -15% | -$37.6M |
2013 Q2
16 quarters
|
|
9
Meta Platforms (Facebook)
META
$1.61T
| $216M | 0.98% |
1,428,043
-68,718
| -5% | -$10.2M |
2013 Q2
16 quarters
|
|
10
Qualcomm
QCOM
$174B
| $197M | 0.89% |
3,561,118
-75,389
| -2% | -$4.21M |
2013 Q2
16 quarters
|
|
11
UnitedHealth
UNH
$367B
| $183M | 0.83% |
987,745
+26,417
| +3% | +$4.63M |
2013 Q2
16 quarters
|
|
12
Ecolab
ECL
$85B
| $179M | 0.81% |
1,350,204
-55,952
| -4% | -$7.23M |
2013 Q2
16 quarters
|
|
13
CNH Industrial
CNH
$18.8B
| $179M | 0.81% |
18,060,605
-645,002
| -3% | -$6.08M |
2013 Q4
14 quarters
|
|
14
Visa
V
$778B
| $179M | 0.81% |
1,903,638
-68,994
| -3% | -$6.4M |
2013 Q2
16 quarters
|
|
15
Booking.com
BKNG
$111B
| $176M | 0.8% |
2,356,175
+76,900
| +3% | +$5.64M |
2013 Q2
16 quarters
|
|
16
PepsiCo
PEP
$189B
| $176M | 0.8% |
1,524,025
-103,109
| -6% | -$11.8M |
2013 Q2
16 quarters
|
|
17
American Express
AXP
$214B
| $173M | 0.79% |
2,055,839
-219,262
| -10% | -$17.3M |
2013 Q2
16 quarters
|
|
18
Amgen
AMGN
$255B
| $168M | 0.76% |
974,085
-104,179
| -10% | -$16.9M |
2013 Q2
16 quarters
|
|
19
Pfizer
PFE
$174B
| $164M | 0.74% |
5,147,638
+164,683
| +3% | +$5.19M |
2013 Q2
16 quarters
|
|
|
CELG
20
DELISTED
Celgene Corp
CELG
| $163M | 0.74% |
1,255,414
-92,396
| -7% | -$11.3M |
2013 Q2
16 quarters
|
|
21
ExxonMobil
XOM
$769B
| $158M | 0.72% |
1,953,443
-143,491
| -7% | -$11.7M |
2013 Q2
16 quarters
|
|
|
22
AT&T
T
$144B
| $146M | 0.66% |
5,106,178
+1,514,358
| +42% | +$44.6M |
2013 Q2
16 quarters
|
|
23
Cisco
CSCO
$412B
| $141M | 0.64% |
4,505,492
+270,416
| +6% | +$8.81M |
2013 Q2
16 quarters
|
|
24
IBM
IBM
$242B
| $141M | 0.64% |
958,712
-127,194
| -12% | -$19.2M |
2013 Q2
16 quarters
|
|
25
AbbVie
ABBV
$523B
| $137M | 0.62% |
1,891,405
-668,302
| -26% | -$44.9M |
2013 Q2
16 quarters
|
|
Similar funds
HI
Axa's Q2 2017 Portfolio in Review
As of Q2 2017, Axa held 1,359 positions worth $22B, down 0.55% from $22.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Axa withdrew a net $1.19B in Q2 2017, closing 125 positions and reducing 517 holdings. Its most notable exit was Mead Johnson Nutrition Company, an estimated $22.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Element Solutions worth $22.3M.
- Axa's largest Q2 2017 buy was Element Solutions: 1,758,931 shares worth $22.3M.
- Axa added most to Micron Technology in Q2 2017, an estimated $62M increase.
- Axa's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $61.6M.
- Axa fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $22.7M.
- Axa's ten largest holdings make up 12% of its $22B portfolio in Q2 2017.
- Axa opened 101 new positions and closed 125 in Q2 2017.
- Axa's portfolio value fell 0.55% quarter-over-quarter to $22B.
Based on Axa's 13F filing for Q2 2017, filed 10 Aug 2017.